STOCK PURCHASE AGREEMENTStock Purchase Agreement • September 29th, 2003 • Genome Therapeutics Corp • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledSeptember 29th, 2003 Company Industry JurisdictionThis Stock Purchase Agreement (this “Agreement”) is made as of December 20, 2002 by and between Genome Therapeutics Corp., a Massachusetts corporation (the “Company”), and Amgen Inc., a Delaware corporation (“Purchaser”).
RESEARCH COLLABORATION AND LICENSE AGREEMENT between Genome Therapeutics Corp. and Amgen Inc.Research Collaboration and License Agreement • September 29th, 2003 • Genome Therapeutics Corp • In vitro & in vivo diagnostic substances • Delaware
Contract Type FiledSeptember 29th, 2003 Company Industry Jurisdictionto sue, Amgen receives payments then such payments shall be included within the definition of Net Sales and the royalty rates as set forth in Section 8.6 shall be applied.